Services

EUNCL will provide a comprehensive set of characterisation tests

EEuropean Nanomedicine Characterization Laboratory (EUNCL) has access to a comprehensive set of characterization tools and assay systems to analyse physical, chemical, in-vitro and in-vivo biological properties allowing researchers in academia, industry and government to translate their nanoproducts towards clinical evaluation more rapidly and for lower cost. The aim is to reduce the development risks and eliminate Med-NPs unfit for clinical use at an early stage.

The EUNCL will offer a comprehensive portfolio of assays (Assay Cascade) that will allow the full characterization of the nanoparticles' physico-chemicals attributes, their in vitro biological properties, and their in vivo compatibility using animal models in a constant quality controlled environment.
After quality pre-check and in adequacy with the nanoparticle type and expected objective, the EUNCL will provide an appropriate set of assays through a dedicated and tired characterization plan.

Proposed nanotechnology materials and strategies submitted to the EUNCL are evaluated according to their projected impact on clinical applications. If a nanotechnology /material is selected for characterization, the EUNCL's services will be provided at no cost to the submitting investigator.

The primary outcome of the EUNCL assay cascade is the collection of data on the nanoparticles' characteristics and their interaction and compatibility with biological systems (in vitro and in vivo). These data will be provided to the sponsor/client through a report to support a CTA application and subsequent clinical trials.

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.
  • Trainee position at JRC (5 months)
    The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.

More News ...